ArticleEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery2026
Five-Year Hospital Readmission After Isolated Coronary Artery Bypass Grafting in the United Kingdom.
Article in European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectivesData on hospital readmission and secondary care utilization after coronary artery bypass grafting (CABG) beyond 30 days remain limited. We aim to address this gap by reporting cardiovascular and procedure-related readmission rates in the 60 months after primary isolated surgical revascularization in the United Kingdom.
methodsAll patients who underwent isolated CABG from January 2013 to April 2025 from the UK National Adult Cardiac Surgery Audit dataset were included. All cause readmissions to any NHS hospital during the first 60 months of follow-up were analysed from the Hospital Episode Statistics dataset. The relation to the time before, during, and after the COVID-19 pandemic was also investigated. Finally, the primary and secondary diagnoses, as well as any procedure(s) undertaken during readmission, were evaluated.
resultsA total of 101,759 patients were identified (84% male, median age 66.9 years [first and third quartile: 59.7, 73.6]). Of these 69,426 patients, required readmission for any cause. The cumulative incidence of readmission at 12 and 60 months was 42.0% and 68.2%, respectively. The overall readmission rate during the first lockdown to the third lockdown relaxation of the COVID-19 pandemic was 42.0% (ranged: 40.7%-45.0%). No significant differences in readmission rates were observed during the COVID-19 pandemic. At 12 months, cardiovascular-related readmissions accounted for 15% (n = 13 529) of all readmissions, with arrhythmia 25%, heart failure 19% and acute coronary syndrome 15.2%. The primary diagnoses between 13 and 60 months 24.7% (n = 17 162) were arrhythmia, 22.2%, angina pectoris, 19.4%, heart failure 17.1%. The overall incidence of urgent repeat revascularization during readmission at 12 and 60 months was 1.71% and 4.20%, respectively. The primary readmission diagnoses related to the surgical procedure (excluding cardiovascular-related) in the first 12 months was 25.5% (n = 23 047), with non-cardiac chest pain 30.1%, surgical wound disruption/infection 16.8% and anaemia 15.0%. Between 13 and 60 months, procedure-related primary diagnoses accounted for 26.1% (n = 18 143), of which non-cardiac chest pain 35.6%, anaemia 26.2%, and respiratory tract infection 20.8%.
conclusionsAnalysis of this unselected UK cohort reveals that cardiovascular-related readmission represented one-quarter of all readmissions at 5 years after the index CABG. This high readmission rate underscores the need for further research to understand the underlying causes and implement strategies to optimize resource use.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.